December 4, 2020
Phase I/II studies to evaluate human placental hematopoietic stem cell–derived natural killer (NK) cell therapy to treat COVID-19 in hospitalized adults are currently ongoing as part of our partnership with the Infectious Disease Research Institute (IDRI).
news & events
Check out what we’ve been up to and where can we connect!
December 4, 2020
ACTT-2 findings support FDA emergency use authorization for baricitinib + remdesivir to treat COVID-19
November 20, 2020
The U.S. FDA granted emergency use authorization (EUA) for the use of baricitinib in combination with remdesivir to treat COVID-19 in hospitalized adults and children at least two years of age requiring supplemental oxygen, invasive mechanical ventilation or extracorporeal membrane oxygenation.
October 20, 2020
Rob King of FHI Clinical recently spoke with the editor for Outsourcing-Pharma about the Oracle Health Sciences and FHI Clinical collaboration to improve clinical trial efficiency and help get therapies to market faster.
Building tuberculosis research capacity through the China Tuberculosis Clinical Trials Consortium (CTCTC) network
October 16, 2020
Development and ongoing activities of the China Tuberculosis Clinical Trials Consortium (CTCTC) were described in an article published in the Infectious Diseases of Poverty journal earlier this year. Read more, including FHI Clinical’s role in providing the network with technical support and guidance for clinical trial capacity building.
September 29, 2020
Register for this virtual plenary session at World Vaccine Congress Washington where panelists will discuss how to incorporate innovation into vaccine clinical trials, including how to apply information from the field to ongoing and future vaccine trials, use of real-world evidence for vaccine efficacy and regulatory perspectives in new development areas.
September 30, 2020
Register for this virtual roundtable at World Vaccine Congress Washington where attendees will discuss how to de-risk vaccine clinical trials in lower resource settings, both globally and within the United States, including how partnerships help achieve social impact.
September 16, 2020
In this webinar hosted by the African Academy of Sciences Clinical Trials Community (CTC), a range of stakeholders will discuss the importance of robust and efficient regulatory and ethics bodies for the clinical trial landscape, role of the WHO African Vaccine Regulatory Forum (AVAREF), and role of the CTC platform in enhancing collaborations and promoting efficiency through shared regulatory and ethics information.